Search for: "Teva Pharmaceuticals"
Results 1301 - 1320
of 1,430
Sorted by Relevance
|
Sort by Date
21 Jun 2019, 6:56 am
Or, to list a few decisions: Netherlands March 1, 2017 District Court (summary proceedings) Lilly/Sandoz Patent valid and infringed (no non-infringement defense) October 24, 2017 District Court (summary proceedings) Lilly/Teva Patent infringed (no invalidity defense) October 24, 2017 District Court (summary proceedings) Lilly/Fresenius Patent infringed May 8, 2018 Court of Appeal (summary proceedings) Teva/Lilly Patent infringed May 8, 2018 Court of Appeal (summary proceedings)… [read post]
1 Apr 2016, 8:22 am
Based upon a logical extension of Teva v. [read post]
20 Jun 2008, 8:07 am
: (Spicy IP), Latin America: Merck Serono signs distribution agreement with Bristol-Myers Squibb for portfolio of established pharmaceutical brands in Latin America: (IP tango), US: Biotech industry growth to slow due to funding pressures and competition from biosimilars: (Managing Intellectual Property), US: House Commerce Committee posts responses to its questions on biogenerics; not surprisingly, the views run the gamut: (FDA Law Blog), US: Biosimilar debate heats up at BIO: (Managing… [read post]
14 Nov 2016, 9:16 am
Teva Pharmaceuticals USA, Inc., et al. [read post]
13 Oct 2016, 6:50 am
Teva Pharmaceuticals USA, Inc., et al. [read post]
16 Jan 2017, 5:44 pm
Teva Pharmaceuticals USA, Inc., et al. [read post]
8 Feb 2017, 3:09 am
Teva Pharmaceuticals USA, Inc., et al. [read post]
11 Jul 2008, 4:30 am
, (Daily Dose of IP), 11-12 September: US LSI: 4th annual conference on ‘Current issues in complex IP licensing’ – Philadelphia: (Patent Docs), 11 September/15 October: PLI seminar on developments in pharmaceutical and biotech patent law – New York/San Francisco: (Patent Docs), 15-16 September: UniForum & SAIIPL domain name ADR workshop – Centurion (South Africa): (Afro-IP), 15-16 September: US ACI 10th advanced forum on biotech… [read post]
19 Sep 2008, 6:00 pm
: (IP finance), United States: An open letter for the General Counsel of the PTO on your San Diego presentation next week: (Hal Wegner), United States: Cocoa genome: breaking intellectual property barriers: (Thomson Reuters Scientific), Vietnam: Patentability of second medical use claims in Vietnam is again questionable: (Trung Truc JSC) Pharma & Biotech - Products Allegra (Fexofenadine) - Canada: Motion for summary judgment of noninfringement dismissed in patent infringement… [read post]
16 Aug 2008, 2:43 am
– discussion of Washington Post article on Ismed’s efforts to promote follow-on biologics approval pathway: (Patent Baristas), (Patent Docs), US: Congressional fact-finding on follow-on biologics: (Patent Docs), US: David v Monsanto: Biotechnology patent ‘exhaustion’ after Quanta, Supreme Court petition: (Hal Wegner), US: Ulysses Pharmaceuticals announces issuance of patent for novel class of ant [read post]
1 Feb 2008, 12:00 am
: (IPBiz),State of the Union address 28 Jan 2008: statement regarding patenting human life: (IPBiz), (Patently-O),Alnylam Pharmaceuticals secures UK patent covering molecules that affect RNA interference: (SmartBrief),Doha style compulsory licences for exports: The politics…: (Spicy IP),Pushing to compulsory licensing: Pharma companies heading closer to Doha: (Spicy IP),Financial Express on the battle between big pharma companies and the… [read post]
18 Jan 2013, 2:06 pm
The Decherts are too involved in this litigation to comment publicly.There aren’t many research-oriented pharmaceutical companies based in Alabama, and after last week’s execrable decision in Wyeth, Inc. v. [read post]
5 Sep 2024, 9:05 pm
There has been a spike in demand for Takeda Pharmaceutical’s Vyvanse since Israel’s invasion of Gaza, triggering manufacturing delays of Adderall, which is produced by Israel-based Teva Pharmaceutical Industries. [read post]
3 Jun 2009, 8:55 pm
The Eastern District of Virginia construed the claims and granted-in-part Lupin's motion for summary judgment of noninfringement, In the Illinois action, Abbott sued Sandoz (and Sandoz GmbH, Teva Pharmaceuticals, Ranbaxy Laboratories, Par Pharmaceutical) for infringement after they wanted to market generic versions of Omnicef. [read post]
15 Feb 2008, 9:00 am
A step behind: (Spicy IP),Proposals for ISPs to terminate infringers go (even more) global: (LawFont.com),Five ways to minimize risk of copyright liability from citizen media: (IP ADR Blog), Pharma & BiotechPharma & Biotech - GeneralMillennium Pharmaceuticals spent $1.28 million on lobbying for patent reform and biologics legislation in 2007: (Patent Docs),New Thai Minister may review compulsory licences on cancer drugs: (Intellectual Property… [read post]
23 Dec 2007, 8:00 pm
You can separately subscribe to the IP Thinktank Global week in Review at [feeds.feedburner.com]GlobalEvents in Bali heap further pressure on all IP owners: (IAM),Velcro defies generic claim in domain name battle: (OUT-LAW),ICANN forms group to hasten non-English domain names: (IP Justice)WTO members continue debate on geographical indications register: (Intellectual Property Watch),Creative Commons launches CCo and CC programs: (World IP Day),Green IP Strategy - risks… [read post]
14 May 2015, 4:00 am
Mylan Pharmaceuticals ULC, 2015 FC 17[7] [tadalafil Notice of Compliance case (“NOC”)], Justice de Montigny accepted that Eli Lilly’s patent for the new use of a drug to treat erectile dysfunction (“ED”) only promised ED treatment. [read post]
26 Sep 2022, 4:49 am
Skinny Label Infringement in Teva Pharmaceuticals USA, Inc. v. [read post]
28 Oct 2011, 2:24 am
Galit heads Teva's European patent litigation operation and in this seminar she presents some original research. [read post]
28 Aug 2014, 7:42 am
If generic drug manufacturers will not be held liable for the harm they inflict on patients, then we should not be forced by our government and health insurers to ingest their generic pharmaceuticals. [read post]
